ID   PACS1_HUMAN             Reviewed;         963 AA.
AC   Q6VY07; Q6PJY6; Q6PKB6; Q7Z590; Q7Z5W4; Q8N8K6; Q96MW0; Q9NW92; Q9ULP5;
DT   13-SEP-2004, integrated into UniProtKB/Swiss-Prot.
DT   13-SEP-2004, sequence version 2.
DT   28-JUN-2023, entry version 167.
DE   RecName: Full=Phosphofurin acidic cluster sorting protein 1;
DE            Short=PACS-1;
GN   Name=PACS1; Synonyms=KIAA1175;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Wan L., Xiang Y., Simmen T., Thomas G.;
RT   "Human PACS-1, a endosome-TGN sorting connector.";
RL   Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Embryo, and Fetal brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, Kidney, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 323-963 (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10574461; DOI=10.1093/dnares/6.5.329;
RA   Hirosawa M., Nagase T., Ishikawa K., Kikuno R., Nomura N., Ohara O.;
RT   "Characterization of cDNA clones selected by the GeneMark analysis from
RT   size-fractionated cDNA libraries from human brain.";
RL   DNA Res. 6:329-336(1999).
RN   [5]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=11331585; DOI=10.1093/emboj/20.9.2191;
RA   Crump C.M., Xiang Y., Thomas L., Gu F., Austin C., Tooze S.A., Thomas G.;
RT   "PACS-1 binding to adaptors is required for acidic cluster motif-mediated
RT   protein traffic.";
RL   EMBO J. 20:2191-2201(2001).
RN   [6]
RP   INTERACTION WITH HIV-1 NEF (MICROBIAL INFECTION).
RX   PubMed=10707087; DOI=10.1038/35004038;
RA   Piguet V., Wan L., Borel C., Mangasarian A., Demaurex N., Thomas G.,
RA   Trono D.;
RT   "HIV-1 Nef protein binds to the cellular protein PACS-1 to downregulate
RT   class I major histocompatibility complexes.";
RL   Nat. Cell Biol. 2:163-167(2000).
RN   [7]
RP   INTERACTION WITH HIV-1 NEF (MICROBIAL INFECTION).
RX   PubMed=12526811; DOI=10.1016/s0092-8674(02)01162-5;
RA   Blagoveshchenskaya A.D., Thomas L., Feliciangeli S.F., Hung C.-H.,
RA   Thomas G.;
RT   "HIV-1 Nef downregulates MHC-I by a PACS-1- and PI3K-regulated ARF6
RT   endocytic pathway.";
RL   Cell 111:853-866(2002).
RN   [8]
RP   INTERACTION WITH PKD2, AND FUNCTION.
RX   PubMed=15692563; DOI=10.1038/sj.emboj.7600566;
RA   Koettgen M., Benzing T., Simmen T., Tauber R., Buchholz B.,
RA   Feliciangeli S., Huber T.B., Schermer B., Kramer-Zucker A., Hoepker K.,
RA   Simmen K.C., Tschucke C.C., Sandford R., Kim E., Thomas G., Walz G.;
RT   "Trafficking of TRPP2 by PACS proteins represents a novel mechanism of ion
RT   channel regulation.";
RL   EMBO J. 24:705-716(2005).
RN   [9]
RP   INTERACTION WITH NPHP1.
RX   PubMed=16308564; DOI=10.1038/sj.emboj.7600885;
RA   Schermer B., Hoepker K., Omran H., Ghenoiu C., Fliegauf M., Fekete A.,
RA   Horvath J., Koettgen M., Hackl M., Zschiedrich S., Huber T.B.,
RA   Kramer-Zucker A., Zentgraf H., Blaukat A., Walz G., Benzing T.;
RT   "Phosphorylation by casein kinase 2 induces PACS-1 binding of nephrocystin
RT   and targeting to cilia.";
RL   EMBO J. 24:4415-4424(2005).
RN   [10]
RP   INTERACTION WITH SORL1.
RX   PubMed=17855360; DOI=10.1074/jbc.m705073200;
RA   Schmidt V., Sporbert A., Rohe M., Reimer T., Rehm A., Andersen O.M.,
RA   Willnow T.E.;
RT   "SorLA/LR11 regulates processing of amyloid precursor protein via
RT   interaction with adaptors GGA and PACS-1.";
RL   J. Biol. Chem. 282:32956-32964(2007).
RN   [11]
RP   INTERACTION WITH SORL1.
RX   PubMed=17646382; DOI=10.1128/mcb.00815-07;
RA   Nielsen M.S., Gustafsen C., Madsen P., Nyengaard J.R., Hermey G., Bakke O.,
RA   Mari M., Schu P., Pohlmann R., Dennes A., Petersen C.M.;
RT   "Sorting by the cytoplasmic domain of the amyloid precursor protein binding
RT   receptor SorLA.";
RL   Mol. Cell. Biol. 27:6842-6851(2007).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [13]
RP   INTERACTION WITH HIV-1 NEF (MICROBIAL INFECTION).
RX   PubMed=18296443; DOI=10.1074/jbc.m707572200;
RA   Atkins K.M., Thomas L., Youker R.T., Harriff M.J., Pissani F., You H.,
RA   Thomas G.;
RT   "HIV-1 Nef binds PACS-2 to assemble a multikinase cascade that triggers
RT   major histocompatibility complex class I (MHC-I) down-regulation: analysis
RT   using short interfering RNA and knock-out mice.";
RL   J. Biol. Chem. 283:11772-11784(2008).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-379; SER-430; THR-504;
RP   SER-529 AND SER-534, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-531, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [20]
RP   INTERACTION WITH EPSTEIN-BARR VIRUS PROTEIN BBLF1 (MICROBIAL INFECTION).
RX   PubMed=22740416; DOI=10.1128/jvi.01126-12;
RA   Chiu Y.F., Sugden B., Chang P.J., Chen L.W., Lin Y.J., Lan Y.C., Lai C.H.,
RA   Liou J.Y., Liu S.T., Hung C.H.;
RT   "Characterization and intracellular trafficking of Epstein-Barr virus
RT   BBLF1, a protein involved in virion maturation.";
RL   J. Virol. 86:9647-9655(2012).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-430; SER-495; THR-504;
RP   SER-519; SER-529 AND SER-534, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-381, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [23]
RP   INTERACTION WITH WDR37.
RX   PubMed=34642815; DOI=10.1007/s00439-021-02384-y;
RA   Sorokina E.A., Reis L.M., Thompson S., Agre K., Babovic-Vuksanovic D.,
RA   Ellingson M.S., Hasadsri L., van Bever Y., Semina E.V.;
RT   "WDR37 syndrome: identification of a distinct new cluster of disease-
RT   associated variants and functional analyses of mutant proteins.";
RL   Hum. Genet. 140:1775-1789(2021).
RN   [24]
RP   VARIANT SHMS TRP-203.
RX   PubMed=23159249; DOI=10.1016/j.ajhg.2012.10.013;
RA   Schuurs-Hoeijmakers J.H., Oh E.C., Vissers L.E., Swinkels M.E.,
RA   Gilissen C., Willemsen M.A., Holvoet M., Steehouwer M., Veltman J.A.,
RA   de Vries B.B., van Bokhoven H., de Brouwer A.P., Katsanis N., Devriendt K.,
RA   Brunner H.G.;
RT   "Recurrent de novo mutations in PACS1 cause defective cranial-neural-crest
RT   migration and define a recognizable intellectual-disability syndrome.";
RL   Am. J. Hum. Genet. 91:1122-1127(2012).
CC   -!- FUNCTION: Coat protein that is involved in the localization of trans-
CC       Golgi network (TGN) membrane proteins that contain acidic cluster
CC       sorting motifs. Controls the endosome-to-Golgi trafficking of furin and
CC       mannose-6-phosphate receptor by connecting the acidic-cluster-
CC       containing cytoplasmic domain of these molecules with the adapter-
CC       protein complex-1 (AP-1) of endosomal clathrin-coated membrane pits.
CC       Involved in HIV-1 nef-mediated removal of MHC-I from the cell surface
CC       to the TGN. Required for normal ER Ca2+ handling in lymphocytes.
CC       Together with WDR37, it plays an essential role in lymphocyte
CC       development, quiescence and survival. Required for stabilizing
CC       peripheral lymphocyte populations (By similarity).
CC       {ECO:0000250|UniProtKB:Q8K212, ECO:0000269|PubMed:11331585,
CC       ECO:0000269|PubMed:15692563}.
CC   -!- SUBUNIT: Associates with AP-1 and AP-3 but not with AP-2 complexes
CC       (PubMed:11331585). Interacts with FURIN (By similarity). Forms a
CC       ternary complex with FURIN and AP-1 (PubMed:11331585). Interacts with
CC       NPHP1; the interaction is dependent of NPHP1 phosphorylation by CK2
CC       (PubMed:16308564). Interacts with PKD2 (via acidic region)
CC       (PubMed:15692563). Interacts with SORL1 (PubMed:17855360,
CC       PubMed:17646382). Interacts with WDR37 (PubMed:34642815).
CC       {ECO:0000250|UniProtKB:Q8K212, ECO:0000269|PubMed:11331585,
CC       ECO:0000269|PubMed:15692563, ECO:0000269|PubMed:16308564,
CC       ECO:0000269|PubMed:17646382, ECO:0000269|PubMed:17855360,
CC       ECO:0000269|PubMed:34642815}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with HIV-1 Nef.
CC       {ECO:0000269|PubMed:10707087, ECO:0000269|PubMed:12526811,
CC       ECO:0000269|PubMed:18296443}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with Epstein-barr virus
CC       protein BBLF1. {ECO:0000269|PubMed:22740416}.
CC   -!- INTERACTION:
CC       Q6VY07; Q92870-2: APBB2; NbExp=3; IntAct=EBI-2555014, EBI-21535880;
CC       Q6VY07; P54253: ATXN1; NbExp=6; IntAct=EBI-2555014, EBI-930964;
CC       Q6VY07; P67870: CSNK2B; NbExp=3; IntAct=EBI-2555014, EBI-348169;
CC       Q6VY07; Q9NZ52: GGA3; NbExp=5; IntAct=EBI-2555014, EBI-447404;
CC       Q6VY07; P42858: HTT; NbExp=18; IntAct=EBI-2555014, EBI-466029;
CC       Q6VY07; P11717: IGF2R; NbExp=2; IntAct=EBI-2555014, EBI-1048580;
CC       Q6VY07; D3DTS7: PMP22; NbExp=3; IntAct=EBI-2555014, EBI-25882629;
CC       Q6VY07; P37840: SNCA; NbExp=3; IntAct=EBI-2555014, EBI-985879;
CC       Q6VY07; Q13148: TARDBP; NbExp=6; IntAct=EBI-2555014, EBI-372899;
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus, trans-Golgi network
CC       {ECO:0000250|UniProtKB:O88588}. Note=Localizes in the perinuclear
CC       region, probably the TGN. {ECO:0000305|PubMed:11331585}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q6VY07-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6VY07-2; Sequence=VSP_011557;
CC   -!- DISEASE: Schuurs-Hoeijmakers syndrome (SHMS) [MIM:615009]: An autosomal
CC       dominant intellectual developmental disorder characterized by
CC       intellectual disability in combination with distinct craniofacial
CC       features and genital abnormalities. {ECO:0000269|PubMed:23159249}.
CC       Note=The disease is caused by variants affecting the gene represented
CC       in this entry.
CC   -!- SIMILARITY: Belongs to the PACS family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH09936.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAB71164.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY320283; AAQ67682.1; -; mRNA.
DR   EMBL; AK001071; BAA91491.1; -; mRNA.
DR   EMBL; AK056361; BAB71164.1; ALT_INIT; mRNA.
DR   EMBL; AK096644; BAC04831.1; -; mRNA.
DR   EMBL; BC003173; AAH03173.1; -; mRNA.
DR   EMBL; BC010096; AAH10096.1; -; mRNA.
DR   EMBL; BC009936; AAH09936.1; ALT_INIT; mRNA.
DR   EMBL; BC052577; AAH52577.1; -; mRNA.
DR   EMBL; BC055288; AAH55288.1; -; mRNA.
DR   EMBL; AB033001; BAA86489.1; -; mRNA.
DR   CCDS; CCDS8129.1; -. [Q6VY07-1]
DR   RefSeq; NP_060496.2; NM_018026.3. [Q6VY07-1]
DR   AlphaFoldDB; Q6VY07; -.
DR   BioGRID; 120816; 43.
DR   CORUM; Q6VY07; -.
DR   IntAct; Q6VY07; 24.
DR   MINT; Q6VY07; -.
DR   STRING; 9606.ENSP00000316454; -.
DR   GlyCosmos; Q6VY07; 3 sites, 1 glycan.
DR   GlyGen; Q6VY07; 3 sites, 1 O-linked glycan (3 sites).
DR   iPTMnet; Q6VY07; -.
DR   PhosphoSitePlus; Q6VY07; -.
DR   BioMuta; PACS1; -.
DR   DMDM; 52000804; -.
DR   EPD; Q6VY07; -.
DR   jPOST; Q6VY07; -.
DR   MassIVE; Q6VY07; -.
DR   MaxQB; Q6VY07; -.
DR   PaxDb; Q6VY07; -.
DR   PeptideAtlas; Q6VY07; -.
DR   ProteomicsDB; 67734; -. [Q6VY07-1]
DR   ProteomicsDB; 67735; -. [Q6VY07-2]
DR   ABCD; Q6VY07; 12 sequenced antibodies.
DR   Antibodypedia; 44366; 104 antibodies from 27 providers.
DR   DNASU; 55690; -.
DR   Ensembl; ENST00000320580.9; ENSP00000316454.4; ENSG00000175115.13. [Q6VY07-1]
DR   GeneID; 55690; -.
DR   KEGG; hsa:55690; -.
DR   MANE-Select; ENST00000320580.9; ENSP00000316454.4; NM_018026.4; NP_060496.2.
DR   UCSC; uc001oha.3; human. [Q6VY07-1]
DR   AGR; HGNC:30032; -.
DR   CTD; 55690; -.
DR   DisGeNET; 55690; -.
DR   GeneCards; PACS1; -.
DR   GeneReviews; PACS1; -.
DR   HGNC; HGNC:30032; PACS1.
DR   HPA; ENSG00000175115; Low tissue specificity.
DR   MalaCards; PACS1; -.
DR   MIM; 607492; gene.
DR   MIM; 615009; phenotype.
DR   neXtProt; NX_Q6VY07; -.
DR   OpenTargets; ENSG00000175115; -.
DR   Orphanet; 329224; Intellectual disability-craniofacial dysmorphism-cryptorchidism syndrome.
DR   PharmGKB; PA134989529; -.
DR   VEuPathDB; HostDB:ENSG00000175115; -.
DR   eggNOG; KOG3709; Eukaryota.
DR   GeneTree; ENSGT00950000183209; -.
DR   HOGENOM; CLU_013074_0_0_1; -.
DR   InParanoid; Q6VY07; -.
DR   OMA; CKHKTRE; -.
DR   OrthoDB; 2878701at2759; -.
DR   PhylomeDB; Q6VY07; -.
DR   TreeFam; TF314240; -.
DR   PathwayCommons; Q6VY07; -.
DR   Reactome; R-HSA-164940; Nef mediated downregulation of MHC class I complex cell surface expression.
DR   SignaLink; Q6VY07; -.
DR   SIGNOR; Q6VY07; -.
DR   BioGRID-ORCS; 55690; 29 hits in 1155 CRISPR screens.
DR   ChiTaRS; PACS1; human.
DR   GeneWiki; PACS1; -.
DR   GenomeRNAi; 55690; -.
DR   Pharos; Q6VY07; Tbio.
DR   PRO; PR:Q6VY07; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; Q6VY07; protein.
DR   Bgee; ENSG00000175115; Expressed in cortical plate and 177 other tissues.
DR   ExpressionAtlas; Q6VY07; baseline and differential.
DR   Genevisible; Q6VY07; HS.
DR   GO; GO:0030137; C:COPI-coated vesicle; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0044325; F:transmembrane transporter binding; IPI:BHF-UCL.
DR   GO; GO:0002260; P:lymphocyte homeostasis; ISS:UniProtKB.
DR   GO; GO:0034067; P:protein localization to Golgi apparatus; IEA:Ensembl.
DR   GO; GO:0072659; P:protein localization to plasma membrane; IMP:BHF-UCL.
DR   InterPro; IPR019381; Phosphofurin_acidic_CS-1.
DR   PANTHER; PTHR13280; PHOSPHOFURIN ACIDIC CLUSTER SORTING PROTEIN; 1.
DR   PANTHER; PTHR13280:SF16; PHOSPHOFURIN ACIDIC CLUSTER SORTING PROTEIN 1; 1.
DR   Pfam; PF10254; Pacs-1; 1.
DR   SUPFAM; SSF81995; beta-sandwich domain of Sec23/24; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Coiled coil; Disease variant;
KW   Golgi apparatus; Host-virus interaction; Intellectual disability;
KW   Phosphoprotein; Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:19413330"
FT   CHAIN           2..963
FT                   /note="Phosphofurin acidic cluster sorting protein 1"
FT                   /id="PRO_0000058171"
FT   REGION          1..72
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          78..97
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          168..175
FT                   /note="Involved in binding to AP-1"
FT   REGION          262..299
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          377..428
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          476..542
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          760..804
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          353..377
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        34..48
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        49..72
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        275..289
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        404..427
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        485..500
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        502..532
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        767..804
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0007744|PubMed:19413330"
FT   MOD_RES         28
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8K212"
FT   MOD_RES         46
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8K212"
FT   MOD_RES         251
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8K212"
FT   MOD_RES         379
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         381
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         430
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         495
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         504
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         519
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         528
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O88588"
FT   MOD_RES         529
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         531
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692"
FT   MOD_RES         534
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         917..963
FT                   /note="AKQQQTMLRVSIDGVEWSDIKFFQLAAQWPTHVKHFPVGLFSGSKAT -> S
FT                   PSLGPSLGPDPSSQPGFPPAGSFPPCHLPLTNPGSEPLIPDRPCSQEWLRTQGPSPALC
FT                   TPQPGHLRPTAPLELFSCPLTPSQKFLHRTSF (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_011557"
FT   VARIANT         203
FT                   /note="R -> W (in SHMS; dbSNP:rs398123009)"
FT                   /evidence="ECO:0000269|PubMed:23159249"
FT                   /id="VAR_069534"
FT   VARIANT         302
FT                   /note="F -> L (in dbSNP:rs12798852)"
FT                   /id="VAR_053797"
FT   CONFLICT        171..220
FT                   /note="Missing (in Ref. 2; BAC04831)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        649
FT                   /note="K -> M (in Ref. 2; BAA91491)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        771
FT                   /note="P -> S (in Ref. 2; BAC04831)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        803
FT                   /note="S -> N (in Ref. 1; AAQ67682)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        882
FT                   /note="K -> L (in Ref. 1; AAQ67682)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   963 AA;  104898 MW;  0F6B2CA24F7CD567 CRC64;
     MAERGGAGGG PGGAGGGSGQ RGSGVAQSPQ QPPPQQQQQQ PPQQPTPPKL AQATSSSSST
     SAAAASSSSS STSTSMAVAV ASGSAPPGGP GPGRTPAPVQ MNLYATWEVD RSSSSCVPRL
     FSLTLKKLVM LKEMDKDLNS VVIAVKLQGS KRILRSNEIV LPASGLVETE LQLTFSLQYP
     HFLKRDANKL QIMLQRRKRY KNRTILGYKT LAVGLINMAE VMQHPNEGAL VLGLHSNVKD
     VSVPVAEIKI YSLSSQPIDH EGIKSKLSDR SPDIDNYSEE EEESFSSEQE GSDDPLHGQD
     LFYEDEDLRK VKKTRRKLTS TSAITRQPNI KQKFVALLKR FKVSDEVGFG LEHVSREQIR
     EVEEDLDELY DSLEMYNPSD SGPEMEETES ILSTPKPKLK PFFEGMSQSS SQTEIGSLNS
     KGSLGKDTTS PMELAALEKI KSTWIKNQDD SLTETDTLEI TDQDMFGDAS TSLVVPEKVK
     TPMKSSKTDL QGSASPSKVE GVHTPRQKRS TPLKERQLSK PLSERTNSSD SERSPDLGHS
     TQIPRKVVYD QLNQILVSDA ALPENVILVN TTDWQGQYVA ELLQDQRKPV VCTCSTVEVQ
     AVLSALLTRI QRYCNCNSSM PRPVKVAAVG GQSYLSSILR FFVKSLANKT SDWLGYMRFL
     IIPLGSHPVA KYLGSVDSKY SSSFLDSGWR DLFSRSEPPV SEQLDVAGRV MQYVNGAATT
     HQLPVAEAML TCRHKFPDED SYQKFIPFIG VVKVGLVEDS PSTAGDGDDS PVVSLTVPST
     SPPSSSGLSR DATATPPSSP SMSSALAIVG SPNSPYGDVI GLQVDYWLGH PGERRREGDK
     RDASSKNTLK SVFRSVQVSR LPHSGEAQLS GTMAMTVVTK EKNKKVPTIF LSKKPREKEV
     DSKSQVIEGI SRLICSAKQQ QTMLRVSIDG VEWSDIKFFQ LAAQWPTHVK HFPVGLFSGS
     KAT
//
